Brookline Capital Markets Downgrades Lisata Therapeutics, Inc (LSTA) to Hold
Brookline Capital Markets analyst Kemp Dolliver downgraded Lisata Therapeutics, Inc ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

